References
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69–90. doi:https://doi.org/10.3322/caac.20107
- Itzkowitz SH. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am. 2006; 35(3):553–71. doi:https://doi.org/10.1016/j.gtc.2006.07.002
- Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48(4):526–35. doi:https://doi.org/10.1136/gut.48.4.526
- Chen T, Li Q, Wu J, Wu Y, Peng W, Li H, Wang J, Tang X, Peng Y, Fu X, et al. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother. 2018; 67(10):1635–46. doi:https://doi.org/10.1007/s00262-018-2233-x
- Yu J, Chen Y, Fu X, Zhou X, Peng Y, Shi L, Chen T, Wu Y. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int J Cancer. 2016; 139(6):1318–26. doi:https://doi.org/10.1002/ijc.30168
- Wu Y, Shi L, Li Q, Wu J, Peng W, Li H, Chen K, Ren Y, Fu X. Microbiota diversity in human colorectal cancer tissues is associated with clinicopathological features. Nutr Cancer. 2019; 71(2):214–22. doi:https://doi.org/10.1080/01635581.2019.1578394
- Higashi D, Futami K, Ishibashi Y, Egawa Y, Maekawa T, Matsui T, Iwashita A, Kuroki M. Clinical course of colorectal cancer in patients with ulcerative colitis. Anticancer Res. 2011; 31(7):2499–504.
- Fukushima K, Tsuchiya K, Kano Y, Horita N, Hibiya S, Hayashi R, Kitagaki K, Negi M, Itoh E, Akashi T, et al. Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell line. Cancer Sci. 2015; 106(8):1000–7. doi:https://doi.org/10.1111/cas.12703
- Taylor NS, Xu S, Nambiar P, Dewhirst FE, Fox JG. Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. J Clin Microbiol. 2007; 45(7):2166–72. doi:https://doi.org/10.1128/JCM.00137-07
- Mladenova-Hristova I, Grekova O, Patel A. Zoonotic potential of Helicobacter spp. J Microbiol Immunol Infect. 2017; 50(3):265–9. doi:https://doi.org/10.1016/j.jmii.2016.11.003
- Gill J, Haydon TG, Rawdon TG, McFadden AMJ, Ha H-J, Shen Z, Feng Y, Pang J, Swennes AG, Paster BJ, et al. Helicobacter bilis and Helicobacter trogontum: infectious causes of abortion in sheep. J Vet Diagn Invest. 2016; 28(3):225–34. doi:https://doi.org/10.1177/1040638716638704
- Haesebrouck F, Pasmans F, Flahou B, Chiers K, Baele M, Meyns T, Decostere A, Ducatelle R. Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev. 2009; 22(2):202–23, Table of Contents. doi:https://doi.org/10.1128/CMR.00041-08
- Fox JG, Yan LL, Dewhirst FE, Paster BJ, Shames B, Murphy JC, Hayward A, Belcher JC, Mendes EN. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol. 1995; 33(2):445–54. doi:https://doi.org/10.1128/JCM.33.2.445-454.1995
- Pandey M, Mishra RR, Dixit R, Jaiswal R, Shukla M, et al. Helicobacter bilis in human gallbladder cancer: results of a case-control study and a meta-analysis. Asian Pac J Cancer Prev. 2010; 11(2):343–7.
- Takayama S, Takahashi H, Matsuo Y, Okada Y, Takeyama H. Effect of Helicobacter bilis infection on human bile duct cancer cells. Dig Dis Sci. 2010; 55(7):1905–10. doi:https://doi.org/10.1007/s10620-009-0946-6
- Fox JG. Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease. Gut. 2007; 56(7):898–900. doi:https://doi.org/10.1136/gut.2006.115428
- Liu Z, Ramer-Tait AE, Henderson AL, Demirkale CY, Nettleton D, Wang C, Hostetter JM, Jergens AE, Wannemuehler MJ. Helicobacter bilis colonization enhances susceptibility to Typhlocolitis following an inflammatory trigger. Dig Dis Sci. 2011; 56(10):2838–48. doi:https://doi.org/10.1007/s10620-011-1701-3
- Atherly T, Mosher C, Wang C, Hostetter J, Proctor A, et al. Helicobacter bilis infection alters mucosal bacteria and modulates colitis development in defined microbiota mice. Inflamm Bowel Dis. 2016; 22(11):2571–81.
- Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL. Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol. 2011; 61(1):1–14. doi:https://doi.org/10.1111/j.1574-695X.2010.00744.x
- Nguyen DD, Muthupalani S, Goettel JA, Eston MA, Mobley M, et al. Colitis and colon cancer in WASP-deficient mice require helicobacter species. Inflamm Bowel Dis. 2013; 19(10):2041–50.
- Wu J, Li Q, Fu X. Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity. Transl Oncol. 2019; 12(6):846–51. doi:https://doi.org/10.1016/j.tranon.2019.03.003
- Umansky V, Schirrmacher V, Rocha M. New insights into tumor-host interactions in lymphoma metastasis. J Mol Med (Berl)). 1996; 74(7):353–63. doi:https://doi.org/10.1007/BF00210630
- Chen L, He Z, Iuga AC, Martins Filho SN, Faith JJ, Clemente JC, Deshpande M, Jayaprakash A, Colombel J-F, Lafaille JJ, et al. Diet modifies colonic microbiota and CD4+ T-cell repertoire to induce flares of colitis in mice with myeloid-cell expression of interleukin 23 . Gastroenterology. 2018; 155(4):1177–91. e1116. doi:https://doi.org/10.1053/j.gastro.2018.06.034
- Zou Y, Li W-Y, Wan Z, Zhao B, He Z-W, Wu Z-G, Huang G-L, Wang J, Li B-B, Lu Y-J, et al. Huangqin-Tang ameliorates TNBS-induced colitis by regulating effector and regulatory CD4(+) T Cells. Biomed Res Int. 2015; 2015:102021 doi:https://doi.org/10.1155/2015/102021
- Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med. 1993; 178(1):237–44. doi:https://doi.org/10.1084/jem.178.1.237
- Steinbach EC, Gipson GR, Sheikh SZ. Induction of murine intestinal inflammation by adoptive transfer of effector CD4+ CD45RB high T cells into immunodeficient mice. J Vis Exp. 2015;(98):52533. doi:https://doi.org/10.3791/52533
- Hirano D, Kudo S. Usefulness of CD4+CD45RBhigh CD25- cell-transferred SCID mice for preclinical evaluation of drugs for inflammatory bowel disease. J Pharmacol Sci. 2009; 110(2):169–81. doi:https://doi.org/10.1254/jphs.08293fp
- Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, Erdman SE. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res. 2006; 66(1):57–61. doi:https://doi.org/10.1158/0008-5472.CAN-05-3445
- Swidsinski A, Dörffel Y, Loening-Baucke V, Theissig F, Rückert JC, Ismail M, Rau WA, Gaschler D, Weizenegger M, Kühn S, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut. 2011; 60(1):34–40. doi:https://doi.org/10.1136/gut.2009.191320
- Woods SE, Ek C, Shen Z, Feng Y, Ge Z, Muthupalani S, Whary MT, Fox JG. Male Syrian Hamsters Experimentally Infected with Helicobacter spp. of the H. bilis Cluster Develop MALT-Associated Gastrointestinal Lymphomas . Helicobacter. 2016; 21(3):201–17. doi:https://doi.org/10.1111/hel.12265
- Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S, et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol. 2010; 222(4):350–66. doi:https://doi.org/10.1002/path.2774
- Repass J, Maherali N, Owen K, Reproducibility Project: Cancer Biology. Reproducibility Project: Cancer B, Reproducibility Project Cancer B. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Elife. 2016;5:e10012. doi:https://doi.org/10.7554/eLife.10012
- Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012; 143(2):382–9. doi:https://doi.org/10.1053/j.gastro.2012.04.054
- Chen T, Li Q, Zhang X, Long R, Wu Y, Wu J, Fu X. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection. Hum Pathol. 2018; 79:93–101. doi:https://doi.org/10.1016/j.humpath.2018.05.008
- Wu Y, Wu J, Chen T, Li Q, Peng W, Li H, Tang X, Fu X. Fusobacterium nucleatum potentiates intestinal tumorigenesis in mice via a toll-like receptor 4/p21-activated kinase 1 cascade. Dig Dis Sci. 2018; 63(5):1210–8. doi:https://doi.org/10.1007/s10620-018-4999-2
- Segura-Lopez FK, Aviles-Jimenez F, Guitron-Cantu A, Valdez-Salazar HA, Leon-Carballo S, et al. Infection with Helicobacter bilis but not Helicobacter hepaticus was associated with extrahepatic cholangiocarcinoma. Helicobacter. 2015; 20(3):223–30.
- Okoli AS, Raftery MJ, Mendz GL. Comparison of Helicobacter bilis-associated protein expression in Huh7 cells harbouring HCV replicon and in replicon-cured cells. Int J Hepatol. 2012; 2012:501671 doi:https://doi.org/10.1155/2012/501671
- Javed S, Mejias-Luque R, Kalali B, Bolz C, Gerhard M. Helicobacter bilis gamma-glutamyltranspeptidase enhances inflammatory stress response via oxidative stress in colon epithelial cells. PLoS One. 2013; 8(8):e73160 doi:https://doi.org/10.1371/journal.pone.0073160
- Saraggi D, Fassan M, Mescoli C, Scarpa M, Valeri N, Michielan A, D'Incá R, Rugge M. The molecular landscape of colitis-associated carcinogenesis. Dig Liver Dis. 2017; 49(4):326–30. doi:https://doi.org/10.1016/j.dld.2016.12.011
- Singh B, Read S, Asseman C, Malmström V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev. 2001; 182:190–200. doi:https://doi.org/10.1034/j.1600-065x.2001.1820115.x
- Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002; 20:495–549. doi:https://doi.org/10.1146/annurev.immunol.20.100301.064816
- Ten Hove T, The Olle F, Berkhout M, Bruggeman JP, Vyth-Dreese FA, Slors JFM, Van Deventer SJH, Te Velde AA. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. J Leukoc Biol. 2004; 75(6):1010–5. doi:https://doi.org/10.1189/jlb.0803400
- Shomer NH, Dangler CA, Schrenzel MD, Fox JG. Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun. 1997; 65(11):4858–64. doi:https://doi.org/10.1128/IAI.65.11.4858-4864.1997
- Reinoso Webb C, den Bakker H, Koboziev I, Jones-Hall Y, Rao Kottapalli K, Ostanin D, Furr KL, Mu Q, Luo XM, Grisham MB, et al. Differential susceptibility to T cell-induced colitis in mice: role of the intestinal microbiota. Inflamm Bowel Dis. 2018; 24(2):361–79. doi:https://doi.org/10.1093/ibd/izx014
- Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012; 22(2):292–8. doi:https://doi.org/10.1101/gr.126573.111
- Li J, Wei Z, Cao S, Tan X, Liu S, Yao Z, Sun T, Li Y, Zhang D, Zhou Y, et al. A pilot study on clinicopathological features and intestinal microflora changes in colorectal cancer patients born over a nine-year period encompassing three years before and after the Great Chinese famine. Cancer Epidemiol. 2019; 59:166–72. doi:https://doi.org/10.1016/j.canep.2019.02.001
- Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C, et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol. 2014; 232(2):199–209. doi:https://doi.org/10.1002/path.4287
- Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008; 118(2):560–70. doi:https://doi.org/10.1172/JCI32453
- Grivennikov S, Karin E, Terzic J, Mucida D, Yu G-Y, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009; 15(2):103–13. doi:https://doi.org/10.1016/j.ccr.2009.01.001
- Yang GY, Taboada S, Liao J. Inflammatory bowel disease: a model of chronic inflammation-induced cancer. Methods Mol Biol. 2009; 511:193–233.
- Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, et al. Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 2013; 23(5):634–46. doi:https://doi.org/10.1016/j.ccr.2013.03.022
- Jung D-Y, Lee H-J, Lee E-N, Lee J, Kim E-Y, Park H-J, Chang C-Y, Lee S-K, Joh J-W, Kwon G-Y, et al. Beneficial effects of simultaneous treatment with 15-deoxyspergualin and monoclonal antibodies to CD45RB and CD154 on murine islet transplantation recipients. Transplantation. 2006; 82(2):188–95. doi:https://doi.org/10.1097/01.tp.0000226175.94546.18